Index
-
Market Cap
12.97B
Enterprise Value
16.56B
Income
643.10M
Sales
6.34B
Book/sh
26.29
Cash/sh
1.02
Employees
42300
IPO
Sep 24, 1986
P/E
20.53
Forward P/E
19.25
PEG
1.75
P/S
2.05
P/B
5.00
P/C
129.46
P/FCF
28.37
EV/EBITDA
10.88
EV/Sales
2.61
Quick Ratio
1.19
Current Ratio
1.09
Debt/Eq
1.05
LT Debt/Eq
1.02
Option/Short
Yes / Yes
EPS (ttm)
6.40
EPS next Y
6.83
EPS next Q
1.60
EPS this Y
14.12%
EPS next Y
9.83%
EPS next 5Y
11.03%
EPS past 3/5Y
27.08% 14.24%
Sales past 3/5Y
10.92% 5.03%
EPS Y/Y TTM
20.85%
Sales Y/Y TTM
9.36%
EPS Q/Q
21.30%
Sales Q/Q
8.93%
Insider Own
1.01%
Insider Trans
-19.37%
Inst Own
98.23%
Inst Trans
-0.79%
ROA
8.70%
ROE
24.84%
ROIC
11.89%
Gross Margin
22.25%
Oper. Margin
18.32%
Profit Margin
10.15%
SMA20
6.13%
SMA50
7.30%
SMA200
19.68%
Trades
Shs Outstand
98.65M
Shs Float
97.65M
52W High
129.96 1.18%
52W Low
92.77 41.74%
Volatility
2.92% 2.75%
ATR (14)
3.82
RSI (14)
64.30
Beta
0.86
Rel Volume
2.30
Avg Volume
956.55K
Volume
2,197,689
Perf Week
4.35%
Perf Month
8.23%
Perf Quarter
18.38%
Perf Half Y
31.49%
Perf YTD
23.88%
Perf Year
4.66%
Perf 3Y
116.09%
Perf 5Y
160.19%
Perf 10Y
316.88%
Prev Close
122.09
Price
131.49
Change %
7.70%
Analysts 14 incl. previous ratings
Rating Distribution 12 Buy · 1 Hold · 1 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside May 28, 2026 Initiated T TD Cowen
Buy $125 -4.9% Oct 11, 2024 Initiated K KeyBanc Capital Markets
Overweight $115 -12.5% Jul 10, 2024 Initiated L Leerink Partners
Outperform $100 -23.9% Mar 06, 2024 Initiated B Barclays
Overweight $95 -27.8% Mar 14, 2023 Initiated B Barclays
Equal Weight $57 -56.7% Sep 24, 2021 Initiated U UBS
Buy $98 -25.5% Aug 02, 2021 Upgrade R Raymond James
Outperform → Strong Buy $95 → $107 -18.6% Nov 23, 2020 Upgrade B Barclays
Equal Weight → Overweight $96 -27.0% Aug 20, 2020 Resumed B Barclays
Equal Weight $71 -46.0% Dec 11, 2019 Downgrade W Wells Fargo
Market Perform → Underperform Oct 22, 2019 Resumed S Stephens
Overweight Sep 17, 2019 Initiated D Deutsche Bank
Hold $70 -46.8% Sep 06, 2019 Upgrade B BofA/Merrill
Neutral → Buy $73 -44.5% Jun 27, 2019 Initiated B BMO Capital Markets
Outperform $72 -45.2% May 30, 2019 Upgrade B Barclays
Equal Weight → Overweight Dec 20, 2018 Initiated J Jefferies
Buy Dec 14, 2018 Initiated B Barclays
Equal Weight Nov 16, 2018 Initiated U UBS
Buy $86 -34.6% Jul 26, 2018 Upgrade P Piper Jaffray
Neutral → Overweight Mar 29, 2018 Resumed M Mizuho
Buy $62 -52.8%
Show Previous Ratings
Oct-29-26 02:20PM
(Earnings Whispers)
+7.70%
Oct-28-26 04:37PM
04:20PM
Oct-26-26 04:30PM
Oct-22-26 04:30PM
08:52AM
Loading…
08:52AM
Oct-20-26 04:48PM
Oct-19-26 04:30PM
Oct-06-26 04:30PM
Oct-01-26 04:30PM
Sep-24-26 04:30PM
Sep-15-26 04:30PM
Aug-10-26 04:30PM
08:28AM
Aug-05-26 05:06PM
(Associated Press)
+12.55%
04:20PM
Loading…
04:20PM
Jul-23-26 08:00AM
Jul-09-26 04:30PM
Jun-24-26 03:09PM
Jun-11-26 07:04PM
Jun-09-26 01:00PM
May-29-26 08:00AM
May-14-26 04:33PM
04:15PM
09:07AM
May-11-26 04:30PM
May-07-26 08:43AM
May-05-26 04:30PM
May-02-26 03:02AM
Apr-30-26 05:02PM
(Associated Press)
+7.48%
04:20PM
Loading…
04:20PM
Apr-23-26 04:30PM
Apr-22-26 04:30PM
Apr-08-26 07:55AM
Apr-07-26 04:30PM
Mar-18-26 04:30PM
Mar-05-26 09:40AM
Mar-03-26 01:54PM
Feb-27-26 12:43PM
Feb-26-26 04:30PM
09:45AM
Feb-24-26 04:30PM
Feb-20-26 12:08PM
Feb-19-26 08:44AM
Feb-18-26 11:04PM
Feb-16-26 02:29PM
Feb-13-26 08:00AM
Feb-12-26 11:21AM
09:40AM
07:30AM
12:37AM
Feb-11-26 01:54PM
09:50AM
Feb-10-26 12:23PM
09:45AM
Feb-09-26 02:08PM
10:20AM
Feb-06-26 06:28PM
04:03PM
11:55AM
Feb-05-26 07:30PM
05:50PM
05:36PM
04:47PM
(Associated Press Finance)
04:20PM
Feb-03-26 10:14PM
Feb-02-26 08:00AM
Jan-14-26 02:30AM
Jan-11-26 10:34PM
Jan-09-26 08:00AM
Jan-06-26 10:48AM
09:45AM
Dec-31-25 01:04PM
12:00PM
Dec-26-25 09:40AM
Dec-22-25 09:14AM
Dec-19-25 09:13AM
Dec-17-25 09:45AM
Dec-09-25 02:16PM
Dec-07-25 11:00PM
Dec-03-25 11:59AM
Dec-02-25 04:30PM
Dec-01-25 09:40AM
Nov-27-25 09:45AM
Nov-26-25 01:00PM
Nov-25-25 08:15AM
Nov-21-25 08:15AM
Nov-14-25 09:40AM
Nov-11-25 12:24PM
09:45AM
Nov-10-25 04:34PM
Nov-05-25 12:36AM
Oct-31-25 06:02PM
08:50AM
Oct-30-25 09:02PM
Oct-29-25 06:39PM
06:00PM
04:58PM
(Associated Press Finance)
04:20PM
09:40AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Price Andrew L Chief Accounting Officer Aug 31 '26 Sale 120.93 5,211 630,166 69,483 Sep 01 12:21 PM Darby John Patrick EVP, Gen Counsel & Secretary Aug 31 '26 Option Exercise 35.06 4,858 170,321 79,899 Sep 01 12:21 PM Darby John Patrick EVP, Gen Counsel & Secretary Aug 31 '26 Sale 121.09 4,858 588,255 75,041 Sep 01 12:21 PM John Patrick Darby Officer Aug 31 '26 Proposed Sale 121.09 4,858 588,256 Aug 31 12:40 PM COLTHARP DOUGLAS E EVP & Chief Financial Officer Aug 10 '26 Sale 125.38 18,869 2,365,795 50,508 Aug 11 02:47 PM Tarr Mark J President & CEO Aug 10 '26 Sale 125.47 173,148 21,724,095 267,814 Aug 11 02:47 PM Darby John Patrick EVP, Gen Counsel & Secretary Aug 10 '26 Sale 125.95 8,906 1,121,711 75,041 Aug 11 02:47 PM Mark Tarr Officer Aug 10 '26 Proposed Sale 125.45 173,148 21,722,175 Aug 10 05:23 PM John Patrick Darby Officer Aug 10 '26 Proposed Sale 125.95 8,906 1,121,701 Aug 10 05:20 PM Douglas Coltharp Officer Aug 10 '26 Proposed Sale 125.38 18,869 2,365,701 Aug 10 05:10 PM COLTHARP DOUGLAS E EVP & Chief Financial Officer May 15 '26 Option Exercise 32.94 27,694 912,240 97,071 May 18 01:16 PM COLTHARP DOUGLAS E EVP & Chief Financial Officer May 15 '26 Sale 106.83 27,694 2,958,550 69,377 May 18 01:16 PM Douglas Edward Coltharp Officer May 15 '26 Proposed Sale 106.83 27,694 2,958,629 May 15 01:19 PM Tuer Patrick William EVP, Chief Operating Officer May 11 '26 Sale 104.56 682 71,310 24,755 May 12 04:16 PM Patrick Tuer Officer May 11 '26 Proposed Sale 104.56 682 71,312 May 11 05:30 PM Fay Edmund Sr. Vice Pres. and Treasurer Mar 09 '26 Sale 107.00 11,937 1,277,259 89,325 Mar 10 01:43 PM Tarr Mark J President & CEO Feb 11 '26 Sale 111.64 150,000 16,746,688 377,070 Feb 12 03:40 PM Mark Tarr Officer Feb 11 '26 Proposed Sale 111.59 150,000 16,738,961 Feb 11 03:05 PM Tuer Patrick William EVP, Chief Operating Officer Feb 10 '26 Sale 107.62 2,804 301,766 16,042 Feb 10 04:30 PM Patrick Tuer Officer Feb 10 '26 Proposed Sale 107.62 2,804 301,755 Feb 10 02:24 PM
Encompass Health Corp. engages in the provision of post-acute healthcare services. It provides specialized rehabilitative treatment on an inpatient basis. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
CEO Mr. Mark J. Tarr
Executive VP & CFO Mr. Douglas E. Coltharp
Executive VP & COO Mr. Patrick W. Tuer
Executive VP Mr. John Patrick Darby
M.S. Dr. Elissa Joy Charbonneau D.O.